Press-release for stocks for csl ltd for AZNCF

| -5.41% | O: 0.41% H: 0.0% C: 0.0%
CSLLY | $87.96 3.3% 45K

| -6.8% | O: -4.92% H: 3.76% C: 3.44%
GLAXF | $20.2 -14.18% 510

| -5.92% | O: -3.4% H: 1.49% C: 1.49%
AZNCF | $140.15 -4.19% 560

| 3.19% | O: 1.55% H: 0.82% C: 0.16%
ALPMY | News | $9.46 -1.11% 500K

| -12.05% | O: -1.41% H: 5.06% C: 4.01%
GSK | $39.27 -0.83% 0.01% 2.2M

| -8.21% | O: -0.6% H: 0.19% C: 0.09%
ABT | News | $105.28 -0.59% 0.0% 7.3M

| -10.65% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -4.06% | O: 0.57% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 2.65% | O: 1.08% H: 0.82% C: 0.67%
pharma vaccine astrazeneca research key market

Renal Anemia Therapeutics Market to Record Growth of USD 2.08 billion from 2023 to 2028, Akebia Therapeutics Inc and Amgen Inc to emerge as Some of the Key Companies - Technavio
Published: 2024-01-29 (Crawled : 00:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50

| -11.05% | O: -1.84% H: 0.52% C: 0.52%
CSLLY | $87.96 3.3% 45K

| -9.68% | O: -0.25% H: 1.0% C: 0.98%
ALPMF | News | $9.594 43.47% 2.2K

| -15.47% | O: 1.76% H: 0.0% C: 0.0%
GLAXF | $20.2 -14.18% 510

| 6.51% | O: 2.93% H: 0.0% C: -1.15%
AZNCF | $140.15 -4.19% 560

| 2.13% | O: 3.1% H: 0.0% C: -3.91%
ALPMY | News | $9.46 -1.11% 500K

| -19.48% | O: -3.53% H: 3.49% C: 3.4%
TVTX | $5.805 -3.09% -3.19% 970K

| -35.73% | O: -1.39% H: 0.16% C: -1.96%
GSK | $39.27 -0.83% 0.01% 2.2M

| 1.38% | O: 0.26% H: 0.13% C: -0.18%
AZN | $68.36 -0.25% -0.25% 4M

| 1.6% | O: 0.24% H: 0.01% C: -0.22%
AMGN | $262.77 -0.49% -0.49% 2M

| -14.84% | O: -0.29% H: 0.76% C: 0.67%
companies renal anemia key therapeutics growth market

Influenza Vaccine Market to grow by USD 2.93 billion from 2022 to 2027; North America to account for 54% of market growth - Technavio
Published: 2023-12-13 (Crawled : 19:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50

| -2.78% | O: 5.56% H: 0.71% C: 0.71%
CSLLY | $87.96 3.3% 45K

| -4.18% | O: 1.46% H: 3.01% C: 0.97%
GLAXF | $20.2 -14.18% 510

| 10.26% | O: 0.58% H: 0.0% C: -1.01%
SNYNF | News | $92.7 -2.18% 1.4K

| -3.35% | O: 0.25% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560

| 4.68% | O: 1.19% H: 3.09% C: 1.3%
GSK | $39.27 -0.83% 0.01% 2.2M

| 7.78% | O: 0.76% H: 1.0% C: -0.11%
BAX | News | $39.65 0.33% 0.0% 2.3M

| 5.5% | O: 1.7% H: 2.44% C: 1.78%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -4.53% | O: 0.0% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 3.59% | O: 1.21% H: 0.27% C: -0.52%
america vaccine influenza growth market

Vaccine research market to grow at a CAGR of 9.88% from 2022 to 2027 | Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players- Technavio
Published: 2023-07-14 (Crawled : 11:00) - prnewswire.com
CSLLY | $87.96 3.3% 45K

| -3.37% | O: -0.54% H: 0.0% C: -1.4%
GLAXF | $20.2 -14.18% 510

| 14.45% | O: 0.0% H: 1.42% C: 0.96%
AZNCF | $140.15 -4.19% 560

| 1.28% | O: 6.03% H: -2.14% C: -2.14%
ALPMY | News | $9.46 -1.11% 500K

| -35.63% | O: 0.96% H: 0.0% C: -1.71%
GSK | $39.27 -0.83% 0.01% 2.2M

| 13.79% | O: 0.03% H: 0.2% C: -0.8%
ABT | News | $105.28 -0.59% 0.0% 7.3M

| 0.18% | O: 0.24% H: 0.44% C: -0.06%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -12.2% | O: 0.36% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 0.82% | O: 1.79% H: 0.0% C: -2.23%
pharma vaccine research market

Orphan drugs market to grow by USD 170.8 billion between 2022 and 2027; Growth driven by rising incidence of rare diseases - Technavio
Published: 2023-05-03 (Crawled : 01:00) - prnewswire.com
CSLLY | $87.96 3.3% 45K

| -12.47% | O: -0.56% H: 0.36% C: -0.28%
AZNCF | $140.15 -4.19% 560

| -7.42% | O: 3.52% H: 0.0% C: 0.0%
NVSEF | News | $93.6375 6.88% 82K

| 10.16% | O: -1.96% H: 0.0% C: 0.0%
ALPMY | News | $9.46 -1.11% 500K

| -38.02% | O: 1.86% H: 0.0% C: -0.65%
NVS | News | $92.57 -0.55% 0.0% 910K

| -10.1% | O: 0.55% H: 0.68% C: 0.33%
GSK | $39.27 -0.83% 0.01% 2.2M

| 8.94% | O: 1.24% H: 1.14% C: 0.11%
ABBV | $164.69 0.27% 0.0% 4.5M

| 8.12% | O: -0.36% H: 0.29% C: -1.2%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -13.65% | O: 0.71% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| -7.37% | O: 0.75% H: 0.98% C: 0.46%
rare growth market

Global Bioengineered Protein Drugs Markets Report 2023: A $521.3 Billion Market by 2027 Featuring AbbVie, AstraZeneca, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Merck and Sanofi
Published: 2023-04-20 (Crawled : 01:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50

| -12.72% | O: -1.07% H: 1.56% C: -0.01%
CSLLY | $87.96 3.3% 45K

| -12.73% | O: 0.23% H: 0.39% C: -0.18%
GLAXF | $20.2 -14.18% 510

| 9.19% | O: -0.08% H: 0.0% C: -0.68%
AZNCF | $140.15 -4.19% 560

| -8.44% | O: 0.42% H: 0.0% C: -0.53%
NVSEF | News | $93.6375 6.88% 82K

| 14.66% | O: 0.61% H: 0.0% C: 0.0%
NVO | News | $122.75 -1.43% 0.0% 2.8M

| -24.54% | O: 0.33% H: 0.36% C: -0.13%
NVS | News | $92.57 -0.55% 0.0% 910K

| -5.04% | O: 0.34% H: 0.28% C: 0.25%
JNJ | News | $145.74 0.67% 0.0% 9.3M

| -10.93% | O: -0.06% H: 0.86% C: 0.71%
GSK | $39.27 -0.83% 0.01% 2.2M

| 7.23% | O: -0.24% H: 0.0% C: -1.03%
ABBV | $164.69 0.27% 0.0% 4.5M

| 1.68% | O: -0.02% H: 0.37% C: 0.35%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -17.16% | O: -0.03% H: 0.0% C: 0.0%
BNTX | $86.19 -0.24% -0.24% 570K

| -29.11% | O: -0.85% H: 1.51% C: 0.15%
AZN | $68.36 -0.25% -0.25% 4M

| -8.79% | O: 0.05% H: 0.11% C: -0.47%
AMGN | $262.77 -0.49% -0.49% 2M

| 8.42% | O: -0.04% H: 0.11% C: -1.08%
ADMA 4 | $6.21 2.82% 2.74% 3M

| 78.03% | O: -0.87% H: 1.17% C: 0.29%
report merck global protein sanofi market

Travel vaccines market size to increase by USD 2.44 billion from 2021 to 2026: Bharat Biotech Ltd. and CSL Ltd. among key vendors - Technavio
Published: 2023-04-13 (Crawled : 00:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50

| -12.06% | O: 2.76% H: 0.0% C: -0.26%
CSLLY | $87.96 3.3% 45K

| -13.34% | O: 0.44% H: 0.83% C: 0.51%
GLAXF | $20.2 -14.18% 510

| 8.89% | O: 0.54% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K

| -18.15% | O: -1.1% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560

| -8.11% | O: 0.0% H: 1.63% C: 1.63%
GSK | $39.27 -0.83% 0.01% 2.2M

| 5.01% | O: 0.85% H: 0.76% C: 0.76%
ABT | News | $105.28 -0.59% 0.0% 7.3M

| 5.24% | O: 0.19% H: 0.93% C: 0.84%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -17.54% | O: 0.29% H: 0.0% C: 0.0%
AVDL | $17.4 -3.28% -3.39% 1.1M

| 85.73% | O: 0.21% H: 6.44% C: 4.41%
AZN | $68.36 -0.25% -0.25% 4M

| -7.45% | O: 0.39% H: 1.05% C: 0.97%
biotech travel market

Sleeping Aids Market size to grow by USD 36,416.19 million from 2022 to 2027, Driven by the growing patient-care services - Technavio
Published: 2023-03-28 (Crawled : 01:00) - prnewswire.com
CSLLY | $87.96 3.3% 45K

| -8.55% | O: -1.19% H: 0.29% C: 0.06%
RYLPF | News | $20.515 3.85% 7K

| 27.85% | O: 0.22% H: 0.0% C: 0.0%
GLAXF | $20.2 -14.18% 510

| 18.75% | O: 3.17% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560

| -1.48% | O: 0.22% H: 0.75% C: 0.75%
GSK | $39.27 -0.83% 0.01% 2.2M

| 13.01% | O: 0.26% H: 0.17% C: -0.09%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -13.06% | O: 2.06% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| -0.68% | O: 0.61% H: 0.07% C: -0.8%
services growing market

Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published: 2023-03-06 (Crawled : 20:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50

| -10.86% | O: -0.86% H: 0.33% C: 0.33%
CSLLY | $87.96 3.3% 45K

| -11.33% | O: -0.02% H: 0.54% C: -1.7%
AZNCF | $140.15 -4.19% 560

| 3.92% | O: -2.57% H: 1.62% C: 1.62%
TMO | News | $541.52 -1.05% 0.61% 2.1M

| -2.02% | O: 0.41% H: 0.39% C: -2.14%
TEVA | $12.78 -3.03% -0.24% 9M

| 33.0% | O: -1.21% H: 0.43% C: -3.58%
TAK | $13.16 0.08% 0.0% 1.3M

| -15.92% | O: 0.83% H: 0.06% C: -1.2%
PRGO | $29.94 -0.33% 0.0% 970K

| -18.72% | O: 0.76% H: 1.91% C: 1.26%
GSK | $39.27 -0.83% 0.01% 2.2M

| 14.95% | O: 0.32% H: 0.17% C: -1.53%
LLY | News | $745.95 -0.64% -0.1% 1.7M

| 135.38% | O: 0.01% H: 0.42% C: -2.62%
CTLT | $55.8 -0.29% 0.0% 1M

| -21.81% | O: 0.11% H: 0.53% C: -5.05%
BMY | $48.295 0.95% 0.0% 11M

| -29.96% | O: 0.41% H: 0.04% C: -1.71%
ALB | News | $111.82 -2.25% 0.0% 2.2M

Process Industries

| -55.0% | O: -0.95% H: 1.02% C: -2.19%
ABBV | $164.69 0.27% 0.0% 4.5M

| 5.57% | O: 0.19% H: 0.06% C: -1.7%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -3.39% | O: 0.65% H: 0.0% C: 0.0%
GILD | $66.16 -1.15% -1.16% 6.4M

| -17.48% | O: 0.23% H: 0.0% C: -1.25%
BIIB | $190.55 -0.84% -0.84% 1.5M

| -27.79% | O: 0.28% H: 0.0% C: -2.26%
AZN | $68.36 -0.25% -0.25% 4M

| 5.74% | O: 0.9% H: 0.28% C: -1.3%
global report market

Influenza Vaccine Market to grow by USD 2.56 Bn by 2026, Market Segmentation by Type and Geography - Technavio
Published: 2022-10-19 (Crawled : 12:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50

| 1.14% | O: -0.59% H: 0.0% C: 0.0%
CSLLY | $87.96 3.3% 45K

| 1.88% | O: 0.38% H: 0.24% C: -0.31%
AZNCF | $140.15 -4.19% 560

| 23.14% | O: -1.21% H: 3.64% C: -0.28%
GSK | $39.27 -0.83% 0.01% 2.2M

| 26.72% | O: 0.96% H: 0.22% C: -0.76%
BAX | News | $39.65 0.33% 0.0% 2.3M

| -28.6% | O: -0.36% H: 1.95% C: -0.14%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| 13.68% | O: -1.37% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 21.97% | O: -0.05% H: 0.13% C: -2.56%
vaccine influenza market

Vaccine Research Market to record USD 13.34 Bn growth; Public end-user segment to exhibit high demand -- Technavio
Published: 2022-10-14 (Crawled : 07:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50

| 1.74% | O: -0.74% H: 0.0% C: 0.0%
MTLHY | $29.93 -11.69% 1.1K

| 33.26% | O: -2.18% H: 3.41% C: -0.0%
CSLLY | $87.96 3.3% 45K

| 0.58% | O: -1.43% H: 3.13% C: -0.59%
ALPMF | News | $9.594 43.47% 2.2K

| -27.04% | O: 2.66% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K

| 22.68% | O: 6.95% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560

| 25.75% | O: 1.95% H: 1.5% C: 1.5%
ALPMY | News | $9.46 -1.11% 500K

| -28.97% | O: 0.46% H: 2.5% C: 0.91%
GSK | $39.27 -0.83% 0.01% 2.2M

| 29.2% | O: 0.59% H: 0.66% C: -0.39%
ABT | News | $105.28 -0.59% 0.0% 7.3M

| 5.33% | O: 0.69% H: 0.72% C: -2.2%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| 18.5% | O: 2.74% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 22.93% | O: 1.22% H: 0.52% C: -2.21%
research vaccine market

USD 28.28 Bn growth expected in Vaccines Market -- Driven by increased funding for vaccine development and new vaccine launches
Published: 2022-09-28 (Crawled : 09:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50

| -5.81% | O: -0.61% H: 0.0% C: 0.0%
MTLHY | $29.93 -11.69% 1.1K

| 28.15% | O: 1.63% H: 0.0% C: -0.48%
CSLLY | $87.96 3.3% 45K

| -3.64% | O: -0.43% H: 1.81% C: 1.44%
GLAXF | $20.2 -14.18% 510

| 40.77% | O: 1.05% H: 4.0% C: 4.0%
AZNCF | $140.15 -4.19% 560

| 27.05% | O: 2.35% H: 0.0% C: -0.68%
ALPMY | News | $9.46 -1.11% 500K

| -28.81% | O: -1.91% H: 2.64% C: 1.94%
GSK | $39.27 -0.83% 0.01% 2.2M

| 38.17% | O: 1.12% H: 2.14% C: 1.66%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| 23.03% | O: 0.83% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 28.22% | O: 0.04% H: 3.14% C: 2.68%
vaccine expected funding growth market

USD 2.44 billion Growth in Travel Vaccines Market Size with 42% of the contribution from North America - Technavio
Published: 2022-08-22 (Crawled : 12:00) - prnewswire.com
MTLHF | $6.325 -5.42% 99

| 15.74% | O: 1.01% H: 0.0% C: 0.0%
CMXHF | $172.54 -19.21% 50

| -10.81% | O: 4.48% H: 0.0% C: 0.0%
MTLHY | $29.93 -11.69% 1.1K

| 8.09% | O: -1.95% H: 0.0% C: 0.0%
CSLLY | $87.96 3.3% 45K

| -12.9% | O: 0.0% H: 0.7% C: -0.18%
GLAXF | $20.2 -14.18% 510

| 20.02% | O: 1.84% H: 0.41% C: 0.12%
SNYNF | News | $92.7 -2.18% 1.4K

| 14.44% | O: 1.54% H: 1.57% C: 1.57%
AZNCF | $140.15 -4.19% 560

| 3.17% | O: 2.39% H: 1.09% C: 1.09%
GSK | $39.27 -0.83% 0.01% 2.2M

| 16.27% | O: -0.12% H: 0.68% C: 0.09%
ABT | News | $105.28 -0.59% 0.0% 7.3M

| -1.94% | O: -0.99% H: 0.31% C: -1.39%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| 12.14% | O: 0.27% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 1.63% | O: 0.49% H: 1.11% C: -0.39%
america travel growth market

Vaccines Market to grow at a CAGR of 4.13% by 2026, Evolving Opportunities with Johnson and Johnson & Bharat Biotech Ltd - Technavio
Published: 2022-08-05 (Crawled : 16:00) - prnewswire.com
MTLHY | $29.93 -11.69% 1.1K

| 8.99% | O: -1.42% H: 0.0% C: -1.18%
CSLLY | $87.96 3.3% 45K

| -14.34% | O: -2.96% H: 3.39% C: 2.91%
ALPMF | News | $9.594 43.47% 2.2K

| -37.47% | O: -2.43% H: 0.0% C: 0.0%
GLAXF | $20.2 -14.18% 510

| -2.01% | O: -6.04% H: 2.59% C: 2.59%
SNYNF | News | $92.7 -2.18% 1.4K

| -4.85% | O: 3.16% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560

| 1.47% | O: 0.59% H: 0.0% C: -4.45%
ALPMY | News | $9.46 -1.11% 500K

| -37.51% | O: 0.03% H: 0.07% C: 0.07%
GSK | $39.27 -0.83% 0.01% 2.2M

| -2.46% | O: -1.26% H: 1.36% C: 1.2%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -6.6% | O: -0.32% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 2.98% | O: -0.63% H: 0.63% C: 0.24%
biotech market

Gainers vs Losers

66%

34%

Top 10 Gainers

AGBA | $1.02 155.0% 60.78% 120M

Finance

INVO | $1.555 104.6% 51.13% 5M

Professional, Scientific, and T...

ISPC | $0.437 105.16% 49.53% 37M

WLGS | $0.92 84.0% 45.65% 900K

OST | $0.499 21.38% 45.26% 1.9M

ZCMD | $2.44 78.1% 43.85% 330K

Commercial Services

XPON | $3.1 60.62% 37.74% 16M

TIRX | $0.7 44.39% 30.74% 58M

BNTC | $6.92 44.17% 30.64% 3.5M